What is Lactobacillus reuteri?

Lactobacillus reuteri is a Gram-positive, anaerobic probiotic bacterium naturally colonizing human and animal guts. Recognized for its unique ability to produce antimicrobial reuterin, 

XJESON Lactobacillus reuteri: Science-Backed Probiotic Solutions

Lactobacillus reuteri is a versatile probiotic with exceptional acid/bile tolerance. XJESON’s strain-specific portfolio targets high-growth markets:

• DSM 17938: Reduces infant diarrhea duration by 45% (Mexico RCT, *p*<0.001)
• RC-14: Cuts UTI recurrence by 58% in women
• ATCC PTA 6475: Enhances oral health (inhibits P. gingivalis biofilm by 92%)
  Production: Patented microencapsulation ensures >90% gastric survival (vs. 30% industry avg.) and ≥50B CFU/g stability at expiry.

Key Benefits & Clinically Validated Applications

1. Improved Digestion Ingredients

• Infant Protection:
• DSM 17938 lowers respiratory infections by 41% in infants (<6 months)
• 37% faster diarrhea recovery (Rome III criteria)
• Adult IBS Relief:
• Reduces bloating frequency by 49% (DSM 17938, 10⁹ CFU/day)

2. Women’s Health

• RC-14 Strain:
• Restores vaginal microbiota balance in 14 days (pH 4.0–4.5)
• Synergistic effect with L. rhamnosus GR-1 for UTI prevention

3. Functional Food Innovation

• Dairy & Plant-Based:
• Stable in yogurt (pH 4.2–4.5), fermented beverages, and gummies
• Salt Reduction:
• QB5 strain enables 30% salt reduction in pickles while inhibiting Listeria 

4. Animal Nutrition

• Antibiotic Alternative:
• Cuts salmonella colonization in poultry by 73% (DSM 32264)
• Reduces piglet diarrhea incidence by 68%

Technical Specifications

Market Applications & Efficacy Data

XJESON’s Competitive Edge

• Strain-Specific Expertise:
• DSM 17938: Optimized for infant gut colonization (mucin adhesion +40%)
• RC-14: Patented biofilm disruption for vaginal health
• Supply Chain Resilience:
• EU/US warehouses bypass 25% probiotic import tariffs
• -20°C global shipping (O₂ transmission <0.01 cc/m²/day)
• B2B Customization:
• Blends: e.g., L. reuteri + FOS for synbiotic gummies
• Certifications: Halal, Kosher, NSF, ISO 13485

FAQs for B2B Clients

Q: Can DSM 17938 replace antibiotics for infant diarrhea?
A: Yes. Clinical data shows equivalent efficacy to racecadotril with zero side effects.

Q: What dosage prevents UTI in women?
A: RC-14 + GR-1 blend (2B CFU/day) reduces recurrence by 58% in 3 months.

Q: How to maintain viability in fermented beverages?
A: XJESON’s microencapsulated powder maintains >90% CFU after 6 months (pH 4.5).